⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27778827 | 0.97 | — | — | |
| SCHEMBL21809205 | 0.97 | ALDH1A1 (0.55) | — | |
| SCHEMBL27998388 | 0.97 | — | — | |
| Water SCHEMBL28089835 | 0.97 | — | — | |
| Water SCHEMBL28089837 | 0.97 | ALDH1A1 (0.48) | — | |
| Hydrochloric Acid SCHEMBL3553269 | 0.97 | — | — | |
| Benzene SCHEMBL28844426 | 0.94 | ALDH1A1 (0.46) | — | |
| SCHEMBL76824 | 0.93 | — | — | |
| SCHEMBL9537676 | 0.90 | ALDH1A1 (0.58) | — | |
| SCHEMBL21291787 | 0.90 | ALDH1A1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4895 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | claimed |
| US-20250361490-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | CELLVIE AG (CH) | 2025-11-27 | — | — | US | claimed |
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| EP-4596041-A2 | FARNESOID X RECEPTOR AGONISTS AND USES THEREOF | Organovo, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4567033-A1 | HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF MUTANT KRAS PROTEIN | Astellas Pharma Inc. (JP) | 2025-06-11 | — | — | EP | claimed |
| EP-4535996-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | cellvie AG (CH) | 2025-04-16 | — | — | EP | claimed |
| EP-4522596-A1 | DIHYDROINDENE DERIVATIVES AS MALT1 INHIBITORS | C4X Discovery Limited (GB) | 2025-03-19 | — | — | EP | claimed |
| CN-119630656-A | Heterocyclic compounds for inducing cleavage of mutant KRAS proteins | 安斯泰来制药株式会社 | 2025-03-14 | — | — | CN | claimed |
| EP-4077334-B1 | FUROINDAZOLE DERIVATIVES | BAYER AG (DE) | 2025-03-12 | — | — | EP | claimed |
| US-4769365-A | Certain carboxylic azetidine derivatives useful in reducing blood cholesterol | SHELL OIL COMPANY (US) | 1988-09-06 | — | — | US | claimed |
| US-4758588-A | Diaminocyclohexane platinum complexes | RESEARCH CORPORATION TECHNOLOGIES (US) | 1988-07-19 | — | — | US | claimed |
| EP-0232017-A1 | Antimicrobial N-acyl-2-azetidinones | THE UPJOHN COMPANY (US) | 1987-08-12 | — | — | EP | claimed |
| WO-1987004429-A1 | ANTIMICROBIAL N-ACYL-2-AZETIDINONES | THE UPJOHN COMPANY (US) | 1987-07-30 | — | — | WO | claimed |
| CN-86103728-A | Preparation reduces the method for the medicament of blood cholesterol levels | — | 1987-05-27 | — | — | CN | claimed |
| US-4665197-A | NITRIC ACID OXIDATION OF 3,3-BIS/HYDROXYMETHYL/AZETIDINE/ | SHELL OIL COMPANY (US) | 1987-05-12 | — | — | US | claimed |
| US-4661516-A | WATER SOLUBLE, ANTITUMOR AGENTS | RESEARCH CORPORATION (US) | 1987-04-28 | — | — | US | claimed |
| EP-0208347-A2 | Use of carboxylic azetidine derivatives for reducing blood cholesterol levels | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-01-14 | — | — | EP | claimed |
| EP-0199413-A2 | Process for preparing azetidine derivatives and novel intermediates therein | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-10-29 | — | — | EP | claimed |
| EP-0130482-A1 | Diaminocyclohexane platinum complexes, process for preparing same and pharmaceutical compositions containing same | Research Corporation (US) | 1985-01-09 | — | — | EP | claimed |